Industry Research Reports

Home > Reports > Chemical & Material > Roflumilast API- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

Roflumilast API- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

Industry: Chemical & Material

Published Date: 2025-01-16

Pages: 126 Pages

Report ld: 3566152

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

The global market for Roflumilast API was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Roflumilast API, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Roflumilast API by region & country, by Type, and by Application.

The Roflumilast API market size, estimations, and forecasts are provided in terms of sales volume (Tons) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Roflumilast API.

MARKET SEGMENTATION

By Company

Huateng Pharma
Chongqing Huapont Pharmaceutical
Interquim SA
Veranova
ALP Pharm
Aspire Lifesciences
Aurobindo Pharma Limited
Glenmark Pharmaceuticals
MSN Laboratories
Melody Healthcare
Mylan Inc
Torrent Pharmaceuticals

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

0.98
0.99
Others

Segment by Application

Medical Pharmaceutical
Scientific Research

biaoTi CHAPTER OUTLINE

Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of Roflumilast API manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Sales, revenue of Roflumilast API in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Sales, revenue of Roflumilast API in country level. It provides sigmate data by Type, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Market Overview

1.1 Roflumilast API Product Introduction

1.2 Global Roflumilast API Market Size Forecast

1.2.1 Global Roflumilast API Sales Value (2020-2031)

1.2.2 Global Roflumilast API Sales Volume (2020-2031)

1.2.3 Global Roflumilast API Sales Price (2020-2031)

1.3 Roflumilast API Market Trends & Drivers

1.3.1 Roflumilast API Industry Trends

1.3.2 Roflumilast API Market Drivers & Opportunity

1.3.3 Roflumilast API Market Challenges

1.3.4 Roflumilast API Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Roflumilast API Players Revenue Ranking (2024)

2.2 Global Roflumilast API Revenue by Company (2020-2025)

2.3 Global Roflumilast API Players Sales Volume Ranking (2024)

2.4 Global Roflumilast API Sales Volume by Company Players (2020-2025)

2.5 Global Roflumilast API Average Price by Company (2020-2025)

2.6 Key Manufacturers Roflumilast API Manufacturing Base and Headquarters

2.7 Key Manufacturers Roflumilast API Product Offered

2.8 Key Manufacturers Time to Begin Mass Production of Roflumilast API

2.9 Roflumilast API Market Competitive Analysis

2.9.1 Roflumilast API Market Concentration Rate (2020-2025)

2.9.2 Global 5 and 10 Largest Manufacturers by Roflumilast API Revenue in 2024

2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Roflumilast API as of 2024)

2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 0.98

3.1.2 0.99

3.1.3 Others

3.2 Global Roflumilast API Sales Value by Type

3.2.1 Global Roflumilast API Sales Value by Type (2020 VS 2024 VS 2031)

3.2.2 Global Roflumilast API Sales Value, by Type (2020-2031)

3.2.3 Global Roflumilast API Sales Value, by Type (%) (2020-2031)

3.3 Global Roflumilast API Sales Volume by Type

3.3.1 Global Roflumilast API Sales Volume by Type (2020 VS 2024 VS 2031)

3.3.2 Global Roflumilast API Sales Volume, by Type (2020-2031)

3.3.3 Global Roflumilast API Sales Volume, by Type (%) (2020-2031)

3.4 Global Roflumilast API Average Price by Type (2020-2031)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Medical Pharmaceutical

4.1.2 Scientific Research

4.2 Global Roflumilast API Sales Value by Application

4.2.1 Global Roflumilast API Sales Value by Application (2020 VS 2024 VS 2031)

4.2.2 Global Roflumilast API Sales Value, by Application (2020-2031)

4.2.3 Global Roflumilast API Sales Value, by Application (%) (2020-2031)

4.3 Global Roflumilast API Sales Volume by Application

4.3.1 Global Roflumilast API Sales Volume by Application (2020 VS 2024 VS 2031)

4.3.2 Global Roflumilast API Sales Volume, by Application (2020-2031)

4.3.3 Global Roflumilast API Sales Volume, by Application (%) (2020-2031)

4.4 Global Roflumilast API Average Price by Application (2020-2031)

5 Segmentation by Region

5.1 Global Roflumilast API Sales Value by Region

5.1.1 Global Roflumilast API Sales Value by Region: 2020 VS 2024 VS 2031

5.1.2 Global Roflumilast API Sales Value by Region (2020-2025)

5.1.3 Global Roflumilast API Sales Value by Region (2026-2031)

5.1.4 Global Roflumilast API Sales Value by Region (%), (2020-2031)

5.2 Global Roflumilast API Sales Volume by Region

5.2.1 Global Roflumilast API Sales Volume by Region: 2020 VS 2024 VS 2031

5.2.2 Global Roflumilast API Sales Volume by Region (2020-2025)

5.2.3 Global Roflumilast API Sales Volume by Region (2026-2031)

5.2.4 Global Roflumilast API Sales Volume by Region (%), (2020-2031)

5.3 Global Roflumilast API Average Price by Region (2020-2031)

5.4 North America

5.4.1 North America Roflumilast API Sales Value, 2020-2031

5.4.2 North America Roflumilast API Sales Value by Country (%), 2024 VS 2031

5.5 Europe

5.5.1 Europe Roflumilast API Sales Value, 2020-2031

5.5.2 Europe Roflumilast API Sales Value by Country (%), 2024 VS 2031

5.6 Asia Pacific

5.6.1 Asia Pacific Roflumilast API Sales Value, 2020-2031

5.6.2 Asia Pacific Roflumilast API Sales Value by Region (%), 2024 VS 2031

5.7 South America

5.7.1 South America Roflumilast API Sales Value, 2020-2031

5.7.2 South America Roflumilast API Sales Value by Country (%), 2024 VS 2031

5.8 Middle East & Africa

5.8.1 Middle East & Africa Roflumilast API Sales Value, 2020-2031

5.8.2 Middle East & Africa Roflumilast API Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Roflumilast API Sales Value Growth Trends, 2020 VS 2024 VS 2031

6.2 Key Countries/Regions Roflumilast API Sales Value

6.2.1 Key Countries/Regions Roflumilast API Sales Value, 2020-2031

6.2.2 Key Countries/Regions Roflumilast API Sales Volume, 2020-2031

6.3 United States

6.3.1 United States Roflumilast API Sales Value, 2020-2031

6.3.2 United States Roflumilast API Sales Value by Type (%), 2024 VS 2031

6.3.3 United States Roflumilast API Sales Value by Application, 2024 VS 2031

6.4 Europe

6.4.1 Europe Roflumilast API Sales Value, 2020-2031

6.4.2 Europe Roflumilast API Sales Value by Type (%), 2024 VS 2031

6.4.3 Europe Roflumilast API Sales Value by Application, 2024 VS 2031

6.5 China

6.5.1 China Roflumilast API Sales Value, 2020-2031

6.5.2 China Roflumilast API Sales Value by Type (%), 2024 VS 2031

6.5.3 China Roflumilast API Sales Value by Application, 2024 VS 2031

6.6 Japan

6.6.1 Japan Roflumilast API Sales Value, 2020-2031

6.6.2 Japan Roflumilast API Sales Value by Type (%), 2024 VS 2031

6.6.3 Japan Roflumilast API Sales Value by Application, 2024 VS 2031

6.7 South Korea

6.7.1 South Korea Roflumilast API Sales Value, 2020-2031

6.7.2 South Korea Roflumilast API Sales Value by Type (%), 2024 VS 2031

6.7.3 South Korea Roflumilast API Sales Value by Application, 2024 VS 2031

6.8 Southeast Asia

6.8.1 Southeast Asia Roflumilast API Sales Value, 2020-2031

6.8.2 Southeast Asia Roflumilast API Sales Value by Type (%), 2024 VS 2031

6.8.3 Southeast Asia Roflumilast API Sales Value by Application, 2024 VS 2031

6.9 India

6.9.1 India Roflumilast API Sales Value, 2020-2031

6.9.2 India Roflumilast API Sales Value by Type (%), 2024 VS 2031

6.9.3 India Roflumilast API Sales Value by Application, 2024 VS 2031

7 Company Profiles

7.1 Huateng Pharma

7.1.1 Huateng Pharma Company Information

7.1.2 Huateng Pharma Introduction and Business Overview

7.1.3 Huateng Pharma Roflumilast API Sales, Revenue, Price and Gross Margin (2020-2025)

7.1.4 Huateng Pharma Roflumilast API Product Offerings

7.1.5 Huateng Pharma Recent Development

7.2 Chongqing Huapont Pharmaceutical

7.2.1 Chongqing Huapont Pharmaceutical Company Information

7.2.2 Chongqing Huapont Pharmaceutical Introduction and Business Overview

7.2.3 Chongqing Huapont Pharmaceutical Roflumilast API Sales, Revenue, Price and Gross Margin (2020-2025)

7.2.4 Chongqing Huapont Pharmaceutical Roflumilast API Product Offerings

7.2.5 Chongqing Huapont Pharmaceutical Recent Development

7.3 Interquim SA

7.3.1 Interquim SA Company Information

7.3.2 Interquim SA Introduction and Business Overview

7.3.3 Interquim SA Roflumilast API Sales, Revenue, Price and Gross Margin (2020-2025)

7.3.4 Interquim SA Roflumilast API Product Offerings

7.3.5 Interquim SA Recent Development

7.4 Veranova

7.4.1 Veranova Company Information

7.4.2 Veranova Introduction and Business Overview

7.4.3 Veranova Roflumilast API Sales, Revenue, Price and Gross Margin (2020-2025)

7.4.4 Veranova Roflumilast API Product Offerings

7.4.5 Veranova Recent Development

7.5 ALP Pharm

7.5.1 ALP Pharm Company Information

7.5.2 ALP Pharm Introduction and Business Overview

7.5.3 ALP Pharm Roflumilast API Sales, Revenue, Price and Gross Margin (2020-2025)

7.5.4 ALP Pharm Roflumilast API Product Offerings

7.5.5 ALP Pharm Recent Development

7.6 Aspire Lifesciences

7.6.1 Aspire Lifesciences Company Information

7.6.2 Aspire Lifesciences Introduction and Business Overview

7.6.3 Aspire Lifesciences Roflumilast API Sales, Revenue, Price and Gross Margin (2020-2025)

7.6.4 Aspire Lifesciences Roflumilast API Product Offerings

7.6.5 Aspire Lifesciences Recent Development

7.7 Aurobindo Pharma Limited

7.7.1 Aurobindo Pharma Limited Company Information

7.7.2 Aurobindo Pharma Limited Introduction and Business Overview

7.7.3 Aurobindo Pharma Limited Roflumilast API Sales, Revenue, Price and Gross Margin (2020-2025)

7.7.4 Aurobindo Pharma Limited Roflumilast API Product Offerings

7.7.5 Aurobindo Pharma Limited Recent Development

7.8 Glenmark Pharmaceuticals

7.8.1 Glenmark Pharmaceuticals Company Information

7.8.2 Glenmark Pharmaceuticals Introduction and Business Overview

7.8.3 Glenmark Pharmaceuticals Roflumilast API Sales, Revenue, Price and Gross Margin (2020-2025)

7.8.4 Glenmark Pharmaceuticals Roflumilast API Product Offerings

7.8.5 Glenmark Pharmaceuticals Recent Development

7.9 MSN Laboratories

7.9.1 MSN Laboratories Company Information

7.9.2 MSN Laboratories Introduction and Business Overview

7.9.3 MSN Laboratories Roflumilast API Sales, Revenue, Price and Gross Margin (2020-2025)

7.9.4 MSN Laboratories Roflumilast API Product Offerings

7.9.5 MSN Laboratories Recent Development

7.10 Melody Healthcare

7.10.1 Melody Healthcare Company Information

7.10.2 Melody Healthcare Introduction and Business Overview

7.10.3 Melody Healthcare Roflumilast API Sales, Revenue, Price and Gross Margin (2020-2025)

7.10.4 Melody Healthcare Roflumilast API Product Offerings

7.10.5 Melody Healthcare Recent Development

7.11 Mylan Inc

7.11.1 Mylan Inc Company Information

7.11.2 Mylan Inc Introduction and Business Overview

7.11.3 Mylan Inc Roflumilast API Sales, Revenue, Price and Gross Margin (2020-2025)

7.11.4 Mylan Inc Roflumilast API Product Offerings

7.11.5 Mylan Inc Recent Development

7.12 Torrent Pharmaceuticals

7.12.1 Torrent Pharmaceuticals Company Information

7.12.2 Torrent Pharmaceuticals Introduction and Business Overview

7.12.3 Torrent Pharmaceuticals Roflumilast API Sales, Revenue, Price and Gross Margin (2020-2025)

7.12.4 Torrent Pharmaceuticals Roflumilast API Product Offerings

7.12.5 Torrent Pharmaceuticals Recent Development

8 Industry Chain Analysis

8.1 Roflumilast API Industrial Chain

8.2 Roflumilast API Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Roflumilast API Sales Model

8.5.2 Sales Channel

8.5.3 Roflumilast API Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.1.1 Research Programs/Design

10.1.1.2 Market Size Estimation

10.1.1.3 Market Breakdown and Data Triangulation

10.1.2 Data Source

10.1.2.1 Secondary Sources

10.1.2.2 Primary Sources

10.2 Author Details

10.3 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. Roflumilast API Market Trends

Table 2. Roflumilast API Market Drivers & Opportunity

Table 3. Roflumilast API Market Challenges

Table 4. Roflumilast API Market Restraints

Table 5. Global Roflumilast API Revenue by Company (2020-2025) & (US$ Million)

Table 6. Global Roflumilast API Revenue Market Share by Company (2020-2025)

Table 7. Global Roflumilast API Sales Volume by Company (2020-2025) & (Tons)

Table 8. Global Roflumilast API Sales Volume Market Share by Company (2020-2025)

Table 9. Global Market Roflumilast API Price by Company (2020-2025) & (US$/Kg)

Table 10. Key Manufacturers Roflumilast API Manufacturing Base and Headquarters

Table 11. Key Manufacturers Roflumilast API Product Type

Table 12. Key Manufacturers Time to Begin Mass Production of Roflumilast API

Table 13. Global Roflumilast API Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Roflumilast API as of 2024)

Table 15. Mergers & Acquisitions, Expansion Plans

Table 16. Global Roflumilast API Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)

Table 17. Global Roflumilast API Sales Value by Type (2020-2025) & (US$ Million)

Table 18. Global Roflumilast API Sales Value by Type (2026-2031) & (US$ Million)

Table 19. Global Roflumilast API Sales Market Share in Value by Type (2020-2025)

Table 20. Global Roflumilast API Sales Market Share in Value by Type (2026-2031)

Table 21. Global Roflumilast API Sales Volume by Type: 2020 VS 2024 VS 2031 (Tons)

Table 22. Global Roflumilast API Sales Volume by Type (2020-2025) & (Tons)

Table 23. Global Roflumilast API Sales Volume by Type (2026-2031) & (Tons)

Table 24. Global Roflumilast API Sales Market Share in Volume by Type (2020-2025)

Table 25. Global Roflumilast API Sales Market Share in Volume by Type (2026-2031)

Table 26. Global Roflumilast API Price by Type (2020-2025) & (US$/Kg)

Table 27. Global Roflumilast API Price by Type (2026-2031) & (US$/Kg)

Table 28. Global Roflumilast API Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)

Table 29. Global Roflumilast API Sales Value by Application (2020-2025) & (US$ Million)

Table 30. Global Roflumilast API Sales Value by Application (2026-2031) & (US$ Million)

Table 31. Global Roflumilast API Sales Market Share in Value by Application (2020-2025)

Table 32. Global Roflumilast API Sales Market Share in Value by Application (2026-2031)

Table 33. Global Roflumilast API Sales Volume by Application: 2020 VS 2024 VS 2031 (Tons)

Table 34. Global Roflumilast API Sales Volume by Application (2020-2025) & (Tons)

Table 35. Global Roflumilast API Sales Volume by Application (2026-2031) & (Tons)

Table 36. Global Roflumilast API Sales Market Share in Volume by Application (2020-2025)

Table 37. Global Roflumilast API Sales Market Share in Volume by Application (2026-2031)

Table 38. Global Roflumilast API Price by Application (2020-2025) & (US$/Kg)

Table 39. Global Roflumilast API Price by Application (2026-2031) & (US$/Kg)

Table 40. Global Roflumilast API Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)

Table 41. Global Roflumilast API Sales Value by Region (2020-2025) & (US$ Million)

Table 42. Global Roflumilast API Sales Value by Region (2026-2031) & (US$ Million)

Table 43. Global Roflumilast API Sales Value by Region (2020-2025) & (%)

Table 44. Global Roflumilast API Sales Value by Region (2026-2031) & (%)

Table 45. Global Roflumilast API Sales Volume by Region (Tons): 2020 VS 2024 VS 2031

Table 46. Global Roflumilast API Sales Volume by Region (2020-2025) & (Tons)

Table 47. Global Roflumilast API Sales Volume by Region (2026-2031) & (Tons)

Table 48. Global Roflumilast API Sales Volume by Region (2020-2025) & (%)

Table 49. Global Roflumilast API Sales Volume by Region (2026-2031) & (%)

Table 50. Global Roflumilast API Average Price by Region (2020-2025) & (US$/Kg)

Table 51. Global Roflumilast API Average Price by Region (2026-2031) & (US$/Kg)

Table 52. Key Countries/Regions Roflumilast API Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031

Table 53. Key Countries/Regions Roflumilast API Sales Value, (2020-2025) & (US$ Million)

Table 54. Key Countries/Regions Roflumilast API Sales Value, (2026-2031) & (US$ Million)

Table 55. Key Countries/Regions Roflumilast API Sales Volume, (2020-2025) & (Tons)

Table 56. Key Countries/Regions Roflumilast API Sales Volume, (2026-2031) & (Tons)

Table 57. Huateng Pharma Company Information

Table 58. Huateng Pharma Introduction and Business Overview

Table 59. Huateng Pharma Roflumilast API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)

Table 60. Huateng Pharma Roflumilast API Product Offerings

Table 61. Huateng Pharma Recent Development

Table 62. Chongqing Huapont Pharmaceutical Company Information

Table 63. Chongqing Huapont Pharmaceutical Introduction and Business Overview

Table 64. Chongqing Huapont Pharmaceutical Roflumilast API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)

Table 65. Chongqing Huapont Pharmaceutical Roflumilast API Product Offerings

Table 66. Chongqing Huapont Pharmaceutical Recent Development

Table 67. Interquim SA Company Information

Table 68. Interquim SA Introduction and Business Overview

Table 69. Interquim SA Roflumilast API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)

Table 70. Interquim SA Roflumilast API Product Offerings

Table 71. Interquim SA Recent Development

Table 72. Veranova Company Information

Table 73. Veranova Introduction and Business Overview

Table 74. Veranova Roflumilast API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)

Table 75. Veranova Roflumilast API Product Offerings

Table 76. Veranova Recent Development

Table 77. ALP Pharm Company Information

Table 78. ALP Pharm Introduction and Business Overview

Table 79. ALP Pharm Roflumilast API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)

Table 80. ALP Pharm Roflumilast API Product Offerings

Table 81. ALP Pharm Recent Development

Table 82. Aspire Lifesciences Company Information

Table 83. Aspire Lifesciences Introduction and Business Overview

Table 84. Aspire Lifesciences Roflumilast API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)

Table 85. Aspire Lifesciences Roflumilast API Product Offerings

Table 86. Aspire Lifesciences Recent Development

Table 87. Aurobindo Pharma Limited Company Information

Table 88. Aurobindo Pharma Limited Introduction and Business Overview

Table 89. Aurobindo Pharma Limited Roflumilast API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)

Table 90. Aurobindo Pharma Limited Roflumilast API Product Offerings

Table 91. Aurobindo Pharma Limited Recent Development

Table 92. Glenmark Pharmaceuticals Company Information

Table 93. Glenmark Pharmaceuticals Introduction and Business Overview

Table 94. Glenmark Pharmaceuticals Roflumilast API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)

Table 95. Glenmark Pharmaceuticals Roflumilast API Product Offerings

Table 96. Glenmark Pharmaceuticals Recent Development

Table 97. MSN Laboratories Company Information

Table 98. MSN Laboratories Introduction and Business Overview

Table 99. MSN Laboratories Roflumilast API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)

Table 100. MSN Laboratories Roflumilast API Product Offerings

Table 101. MSN Laboratories Recent Development

Table 102. Melody Healthcare Company Information

Table 103. Melody Healthcare Introduction and Business Overview

Table 104. Melody Healthcare Roflumilast API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)

Table 105. Melody Healthcare Roflumilast API Product Offerings

Table 106. Melody Healthcare Recent Development

Table 107. Mylan Inc Company Information

Table 108. Mylan Inc Introduction and Business Overview

Table 109. Mylan Inc Roflumilast API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)

Table 110. Mylan Inc Roflumilast API Product Offerings

Table 111. Mylan Inc Recent Development

Table 112. Torrent Pharmaceuticals Company Information

Table 113. Torrent Pharmaceuticals Introduction and Business Overview

Table 114. Torrent Pharmaceuticals Roflumilast API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)

Table 115. Torrent Pharmaceuticals Roflumilast API Product Offerings

Table 116. Torrent Pharmaceuticals Recent Development

Table 117. Key Raw Materials Lists

Table 118. Raw Materials Key Suppliers Lists

Table 119. Roflumilast API Downstream Customers

Table 120. Roflumilast API Distributors List

Table 121. Research Programs/Design for This Report

Table 122. Key Data Information from Secondary Sources

Table 123. Key Data Information from Primary Sources

List of Figures

Figure 1. Roflumilast API Product Picture

Figure 2. Global Roflumilast API Sales Value, 2020 VS 2024 VS 2031 (US$ Million)

Figure 3. Global Roflumilast API Sales Value (2020-2031) & (US$ Million)

Figure 4. Global Roflumilast API Sales Volume (2020-2031) & (Tons)

Figure 5. Global Roflumilast API Sales Price (2020-2031) & (US$/Kg)

Figure 6. Roflumilast API Report Years Considered

Figure 7. Global Roflumilast API Players Revenue Ranking (2024) & (US$ Million)

Figure 8. Global Roflumilast API Players Sales Volume Ranking (2024) & (Tons)

Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Roflumilast API Revenue in 2024

Figure 10. Roflumilast API Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 11. 0.98 Picture

Figure 12. 0.99 Picture

Figure 13. Others Picture

Figure 14. Global Roflumilast API Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)

Figure 15. Global Roflumilast API Sales Value Market Share by Type, 2024 & 2031

Figure 16. Global Roflumilast API Sales Volume by Type (2020 VS 2024 VS 2031) & (Tons)

Figure 17. Global Roflumilast API Sales Volume Market Share by Type, 2024 & 2031

Figure 18. Global Roflumilast API Price by Type (2020-2031) & (US$/Kg)

Figure 19. Product Picture of Medical Pharmaceutical

Figure 20. Product Picture of Scientific Research

Figure 21. Global Roflumilast API Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)

Figure 22. Global Roflumilast API Sales Value Market Share by Application, 2024 & 2031

Figure 23. Global Roflumilast API Sales Volume by Application (2020 VS 2024 VS 2031) & (Tons)

Figure 24. Global Roflumilast API Sales Volume Market Share by Application, 2024 & 2031

Figure 25. Global Roflumilast API Price by Application (2020-2031) & (US$/Kg)

Figure 26. North America Roflumilast API Sales Value (2020-2031) & (US$ Million)

Figure 27. North America Roflumilast API Sales Value by Country (%), 2024 VS 2031

Figure 28. Europe Roflumilast API Sales Value, (2020-2031) & (US$ Million)

Figure 29. Europe Roflumilast API Sales Value by Country (%), 2024 VS 2031

Figure 30. Asia Pacific Roflumilast API Sales Value, (2020-2031) & (US$ Million)

Figure 31. Asia Pacific Roflumilast API Sales Value by Region (%), 2024 VS 2031

Figure 32. South America Roflumilast API Sales Value, (2020-2031) & (US$ Million)

Figure 33. South America Roflumilast API Sales Value by Country (%), 2024 VS 2031

Figure 34. Middle East & Africa Roflumilast API Sales Value, (2020-2031) & (US$ Million)

Figure 35. Middle East & Africa Roflumilast API Sales Value by Country (%), 2024 VS 2031

Figure 36. Key Countries/Regions Roflumilast API Sales Value (%), (2020-2031)

Figure 37. Key Countries/Regions Roflumilast API Sales Volume (%), (2020-2031)

Figure 38. United States Roflumilast API Sales Value, (2020-2031) & (US$ Million)

Figure 39. United States Roflumilast API Sales Value by Type (%), 2024 VS 2031

Figure 40. United States Roflumilast API Sales Value by Application (%), 2024 VS 2031

Figure 41. Europe Roflumilast API Sales Value, (2020-2031) & (US$ Million)

Figure 42. Europe Roflumilast API Sales Value by Type (%), 2024 VS 2031

Figure 43. Europe Roflumilast API Sales Value by Application (%), 2024 VS 2031

Figure 44. China Roflumilast API Sales Value, (2020-2031) & (US$ Million)

Figure 45. China Roflumilast API Sales Value by Type (%), 2024 VS 2031

Figure 46. China Roflumilast API Sales Value by Application (%), 2024 VS 2031

Figure 47. Japan Roflumilast API Sales Value, (2020-2031) & (US$ Million)

Figure 48. Japan Roflumilast API Sales Value by Type (%), 2024 VS 2031

Figure 49. Japan Roflumilast API Sales Value by Application (%), 2024 VS 2031

Figure 50. South Korea Roflumilast API Sales Value, (2020-2031) & (US$ Million)

Figure 51. South Korea Roflumilast API Sales Value by Type (%), 2024 VS 2031

Figure 52. South Korea Roflumilast API Sales Value by Application (%), 2024 VS 2031

Figure 53. Southeast Asia Roflumilast API Sales Value, (2020-2031) & (US$ Million)

Figure 54. Southeast Asia Roflumilast API Sales Value by Type (%), 2024 VS 2031

Figure 55. Southeast Asia Roflumilast API Sales Value by Application (%), 2024 VS 2031

Figure 56. India Roflumilast API Sales Value, (2020-2031) & (US$ Million)

Figure 57. India Roflumilast API Sales Value by Type (%), 2024 VS 2031

Figure 58. India Roflumilast API Sales Value by Application (%), 2024 VS 2031

Figure 59. Roflumilast API Industrial Chain

Figure 60. Roflumilast API Manufacturing Cost Structure

Figure 61. Channels of Distribution (Direct Sales, and Distribution)

Figure 62. Bottom-up and Top-down Approaches for This Report

Figure 63. Data Triangulation

Figure 64. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

Which companies rank high in the global Roflumilast API market? zhanKai

The top companies in the global Roflumilast API market are Huateng Pharma、Chongqing Huapont Pharmaceutical、Interquim SA.

Related Reports

Roflumilast API- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Roflumilast API was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-06-16
Pages: 144
USD 3950.00
(Single User License)
Global Roflumilast API Market Research Report 2026
The global Roflumilast API market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-04-18
Pages: 142
USD 2900.00
(Single User License)
Global Roflumilast API Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Roflumilast API market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-11-09
Pages: 92
USD 4250.00
(Single User License)
Global Roflumilast API Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Roflumilast API market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-11-09
Pages: 162
USD 4900.00
(Single User License)
Global Roflumilast API Market Research Report 2025
The global market for Roflumilast API was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-01-16
Pages: 97
USD 2900.00
(Single User License)
Global Roflumilast API Market Research Report 2024
The global Roflumilast API market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Published Date: 2024-02-07
Pages: 102
USD 2900.00
(Single User License)

Roflumilast API- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Roflumilast API was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-06-16
Pages: 144
USD 3950.00 (Single User License)
Global Roflumilast API Market Research Report 2026
The global Roflumilast API market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-04-18
Pages: 142
USD 2900.00 (Single User License)
Global Roflumilast API Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Roflumilast API market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-11-09
Pages: 92
USD 4250.00 (Single User License)
Global Roflumilast API Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Roflumilast API market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-11-09
Pages: 162
USD 4900.00 (Single User License)
Global Roflumilast API Market Research Report 2025
The global market for Roflumilast API was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-01-16
Pages: 97
USD 2900.00 (Single User License)
Global Roflumilast API Market Research Report 2024
The global Roflumilast API market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Published: 2024-02-07
Pages: 102
USD 2900.00 (Single User License)